Bronchogenic carcinoma in young patients

Area of Science:

• Oncology
• Pulmonology
• Cancer Research

Background:

• Lung cancer is less common in patients under 40.
• There is a perception that lung cancer in younger individuals follows a more aggressive course with a poorer prognosis.
• This study investigates lung cancer characteristics and outcomes in young patients.

Purpose of the Study:

• To analyze the clinical characteristics, treatment patterns, and survival outcomes of lung cancer in patients under 40 years of age.
• To compare outcomes in young lung cancer patients with those from a previous decade.
• To identify prognostic factors influencing survival in this demographic.

Main Methods:

• Retrospective review of 76 patients under 40 with bronchogenic carcinoma treated between 1984 and 1994.
• Comparison with a historical cohort from the preceding decade.
• Analysis of patient demographics, histology, disease stage, treatment modalities, and survival data.

Main Results:

• The predominant histologic types were adenocarcinoma (43%) and undifferentiated large-cell carcinoma (29%).
• Most patients (83%) presented with Stage IIIa or greater disease.
• Median survival was 10.4 months with a 5-year survival rate of 8%. Stage of disease was the only independent predictor of survival.
• Slightly improved resectability (34% vs. 21%) and marginally better survival (median 10.4 vs. 7.5 months) were observed compared to the previous decade.

Conclusions:

• Young patients with lung cancer frequently present with advanced-stage disease.
• Despite challenges, outcomes show marginal improvement over time.
• Treatment should follow established stage-specific guidelines for optimal management.